Literature DB >> 15925843

Pathomechanisms in celiac disease.

Frits Koning1, Detlef Schuppan, Nadine Cerf-Bensussan, Ludvig M Sollid.   

Abstract

Celiac disease is an inflammatory disorder of the small intestine caused by an immune response to ingested wheat gluten and similar proteins of rye and barley. It affects at least 1 in 200 individuals, corresponding to roughly three million patients in Western Europe and Northern America alone. Data accumulated since the discovery of gluten specific T cells in the intestine of celiac disease patients the early 1990s have allowed the deciphering of the interplay between the triggering environmental factor, gluten, the main genetic risk factor, the HLA-DQ2/8 haplotypes and the autoantigen; the enzyme tissue transglutaminase (tTG). This established a key role of adaptive immunity orchestrated by lamina propria T cells responding to a set of gluten derived peptides. More recent work points to an important contribution of innate immunity triggered by a distinct gluten peptide and driven by the proinflammatory cytokine Interleukine-5 (IL-15). Together, these observations provide a unique explanation for the disease inducing capacity of gluten.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15925843     DOI: 10.1016/j.bpg.2005.02.003

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  23 in total

1.  Proximal muscle weakness as a result of osteomalacia associated with celiac disease: a case report.

Authors:  B Oz; O Akan; H Kocyigit; H A Gürgan
Journal:  Osteoporos Int       Date:  2015-08-27       Impact factor: 4.507

Review 2.  Effector and suppressor T cells in celiac disease.

Authors:  Giuseppe Mazzarella
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

3.  [Clinical features and diagnosis of celiac disease].

Authors:  J Stein
Journal:  Internist (Berl)       Date:  2006-09       Impact factor: 0.743

Review 4.  Coeliac disease: an update for pathologists.

Authors:  B C Dickson; C J Streutker; R Chetty
Journal:  J Clin Pathol       Date:  2006-10       Impact factor: 3.411

5.  Duodenal-mucosal bacteria associated with celiac disease in children.

Authors:  Ester Sánchez; Ester Donat; Carmen Ribes-Koninckx; Maria Leonor Fernández-Murga; Yolanda Sanz
Journal:  Appl Environ Microbiol       Date:  2013-07-08       Impact factor: 4.792

6.  Diagnosis and treatment of coeliac disease.

Authors:  Karel Geboes; Karen P Geboes
Journal:  F1000 Med Rep       Date:  2009-04-29

7.  Coeliac disease-specific autoantibodies targeted against transglutaminase 2 disturb angiogenesis.

Authors:  E Myrsky; K Kaukinen; M Syrjänen; I R Korponay-Szabó; M Mäki; K Lindfors
Journal:  Clin Exp Immunol       Date:  2008-02-14       Impact factor: 4.330

8.  Detailed analysis of the expression of an alpha-gliadin promoter and the deposition of alpha-gliadin protein during wheat grain development.

Authors:  T W J M Van Herpen; M Riley; C Sparks; H D Jones; C Gritsch; E H Dekking; R J Hamer; D Bosch; E M J Salentijn; M J M Smulders; P R Shewry; L J W J Gilissen
Journal:  Ann Bot       Date:  2008-07-11       Impact factor: 4.357

9.  Antibody responses to deamidated gliadin peptide show high specificity and parallel antibodies to tissue transglutaminase in developing coeliac disease.

Authors:  M Ankelo; V Kleimola; S Simell; O Simell; M Knip; E Jokisalo; M Tarkia; A Westerlund; Q He; M Viander; J Ilonen; A E Hinkkanen
Journal:  Clin Exp Immunol       Date:  2007-09-04       Impact factor: 4.330

10.  HLA DQ gene dosage and risk and severity of celiac disease.

Authors:  Joseph A Murray; S Breanndan Moore; Carol T Van Dyke; Brian D Lahr; Ross A Dierkhising; Alan R Zinsmeister; L Joseph Melton; Cynthia M Kroning; Mounif El-Yousseff; Albert J Czaja
Journal:  Clin Gastroenterol Hepatol       Date:  2007-10-24       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.